Retatrutide 10mg Research Peptide

Retatrutide is a triple receptor agonist research peptide currently being studied for its potential effects on metabolic pathways, appetite regulation, energy expenditure, and fat metabolism. It has become an important compound in obesity and metabolic research due to its unique activity across the GLP-1, GIP, and glucagon receptors.

Retatrutide is also commonly referred to as Reta or Reta peptide within the research community. Alternative spellings and abbreviations may also appear in scientific discussions and online research forums.

• Triple GLP-1 / GIP / Glucagon Receptor Agonist

Retatrutide is designed to activate three metabolic hormone receptors simultaneously, making it a unique research peptide for studying energy balance, body composition, and metabolic function.

Key Research Applications

• Fat metabolism and body composition research
• Appetite regulation and food intake studies
• Energy expenditure and metabolic rate research
• Glucose and metabolic marker investigations
• Comparative peptide research alongside other metabolic compounds

Product Information

• Strength: 10mg per vial
• Lyophilised (freeze-dried) research peptide
• High-purity laboratory grade
• Batch-specific Certificate of Analysis (CoA) available
• Fast Australia-wide shipping

Important Notice

This product is supplied strictly for laboratory and in-vitro research purposes only.

Not for human consumption. Not intended for therapeutic, diagnostic, veterinary, or clinical use.